NOD2 and colonic neoplasm: T-MPs were mostly taken up by intestinal epithelial cells (IECs), where they could activate NOD2 and its downstream MAPK and NF-κB, inhibiting the formation of B16 melanoma and CT26 colon cancer in mice.